Insider trade

Director received an award of 367 STE derivative securities

Traded Jun 2, 2026 · Filed Jun 4, 2026

SterisSTE

367
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 2, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 4, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001628280-26-040832
Filed / recorded

Jun 4, 2026, 8:31 PM UTC

Added to OQRO

Oct 2, 2026, 12:26 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

STERIS plc

Issuer CIK

1757898

Ticker

STE

Reporting person

Pierre Boulud

Relationship

Director

Security

Career Restricted Stock Units

Table

Derivative (Table II)

Transaction date

Jun 2, 2026

Transaction code

A

Shares / units

367

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

367

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.